National Standards of Practice for Breast and Cervical Cancer Prevention, Early Detection, Diagnosis, Treatment and Palliative Care

Objectives

Establish resource-appropriate national standards for breast and cervical cancer across the full continuum of prevention, early detection, diagnosis, treatment, survivorship and palliative care, using core, expanded and desirable service levels suited to the Federated States of Micronesia.[1][2][3]The standards aim to reduce cancer risk, improve timely detection and access to care, and ensure that patients are supported through linked and integrated services.[1]

• Promote primary prevention and risk assessment through culturally appropriate, evidence-based programmes that address women’s knowledge, beliefs, practices and relevant cancer risks.[4]
• Strengthen tobacco control through measures aligned with the World Health Organization Framework Convention on Tobacco Control, including smoke-free environments, advertising and packaging restrictions, taxation, cessation support, action on illicit trade and protection from tobacco exposure.[4][5]
• Reduce obesity-related cancer risks by encouraging healthy weight, nutritious diets, lower consumption of processed and high-sugar foods, increased intake of fruit, vegetables, legumes, whole grains, nuts and fish, and greater physical activity.[5]
• Prevent harms associated with physical inactivity and alcohol misuse through primary-care advice, behavioural interventions, tailored activity plans, follow-up support and community-based programmes, including measures addressing underage drinking.[3]
• Advance sexual health education and human papillomavirus vaccination as components of cervical cancer prevention.[3][6]
• Improve early detection through breast cancer awareness, breast examination and education, cervical screening, self-examination education, and public understanding of prevention, treatment and palliative care.[6][7][8]
• Provide cervical cancer screening and treatment at progressively enhanced resource levels, beginning with visual inspection with acetic acid and cryotherapy, with Pap testing, diagnostic capacity and treatment expanded where resources permit.[3][6]
• Deliver breast cancer diagnosis and treatment through tiered standards covering clinical assessment, biopsy, pathology, receptor testing, imaging, laboratory investigations, surgery, radiotherapy, chemotherapy, endocrine therapy and supportive care.[9][10]
• Ensure palliative care at all levels of the health system, particularly through primary-health-care clinics and home-based care, with access to oral morphine, other affordable essential medicines and nationally agreed protocols.[7]
• Link cancer services with maternal and child health, HIV/AIDS, immunisation and non-communicable disease programmes, while supporting cancer survivors as advocates.[8]

Implementation

Implement the standards through collaboration between the national health ministry, state health departments in Kosrae, Chuuk, Pohnpei and Yap, cancer-control stakeholders and communities, adapting evidence-based international guidance to local culture, resources and service capacity.[1][2][11][12][13]Delivery is intended to be phased across core, expanded and desirable levels, allowing services to develop from basic prevention, assessment and referral to more specialised diagnostic, treatment and supportive-care capacity.[2][3][9]

• Coordinate national and state implementation through the Federated States of Micronesia National Department of Health and Social Affairs, state departments of health services, cancer-control coordinators and coalitions, with national leadership sought from the Secretary of Health.[1][8]
• Map assets, consult technical experts and local institutions, and identify roles, resources, service linkages and state-level adaptations needed to apply the standards.[1]
• Engage health professionals, public-health practitioners, maternal and child health and immunisation staff, cancer survivors, community and religious leaders, women’s groups, men’s groups, teachers, midwives, traditional healers, the Red Cross and other influential community organisations.[1][6][7][8]
• Use focus groups, interviews and surveys to understand local knowledge, beliefs and practices and to tailor prevention programmes and human papillomavirus campaign messages.[4][8]
• Integrate tobacco-use screening, dependence treatment and counselling into national health programmes and primary care, including screening of adults and pregnant women and use of the Assess, Advise, Agree, Assist and Arrange framework.[5]
• Provide obesity screening using body mass index or waist-to-hip ratio, alongside intensive counselling, nutrition education, diet and exercise advice, behavioural strategies and maintenance support.[5]
• Use client education, reminders, targeted outreach and community participation to improve breast and cervical cancer screening and early detection.[6]
• Establish provider protocols for abnormal-result follow-up, patient reminders and recalls, and arrange off-island referral for some advanced cervical cancer cases.[6]
• Deliver palliative care through primary care and home-based services, supported by a palliative-care reference group, Cancer Resource Center and central opioid storage and distribution centre.[7]
• Develop locally adapted training curricula, community workshops and continuing medical education covering the cancer continuum for professional and lay audiences.[7]
• Share learning between states through a website, twice-yearly meetings, conference calls and email, and use feedback on provider performance to support early-detection service implementation.[6][8]
• Draw on guidance from bodies including the World Health Organization, United States Preventive Services Task Force, National Cancer Institute, Centers for Disease Control and Prevention, American Cancer Society, Breast Health Global Initiative, Alliance for Cervical Cancer Prevention, PATH and National Comprehensive Cancer Network.[11][12][13]
• Develop evaluation methods and performance measures for compliance with national standards, although final indicators, reporting arrangements, surveillance systems and formal accountability procedures are not specified.[2]
• Mobilise technical support from the Pacific Center of Excellence in the Elimination of Disparities, the University of Hawaii, the National Cancer Institute Cancer Information Service-Pacific Region, the Secretariat of the Pacific Community and other partners; programme budgets and domestic funding commitments are not specified.[1]

Monitoring & Evaluation

Monitoring and evaluation are only partially developed: the standards call for evaluation methods and performance measures to assess compliance, while selected operational mechanisms support follow-up and service-quality feedback; a comprehensive national monitoring, reporting and surveillance framework is not specified.[2][6]

• Develop evaluation methods and performance measures to track compliance with national standards.[2]
• Monitor health providers delivering breast and cervical cancer early-detection services and provide feedback on their performance.[6]
• Apply provider protocols for abnormal-result follow-up, patient reminders and recalls, creating practical mechanisms to support continuity of care and follow-up accountability.[6]
• Use focus-group discussions to identify women’s knowledge, beliefs and practices, adapt prevention programmes to local contexts, and shape human papillomavirus campaign messages.[4][8]
• Share state-level experiences and best practices through a website, twice-yearly meetings, conference calls and email.[8]
• Gather local evidence through focus groups, interviews and surveys to inform culturally adapted breast and cervical cancer prevention interventions.[4]
• Maintain service standards across core, expanded and desirable levels of provision, providing a structured basis against which availability and implementation could be assessed.[2][3][9]
• Recognise that the source does not provide final quantitative indicators, indicator definitions, baselines, targets, data sources, reporting frequencies, named reporting entities, audit processes or formal enforcement procedures.[2][6][7][11][12][13]
• Recognise that the source does not set out a cancer-registry model or other formal surveillance system for breast or cervical cancer incidence, service coverage, treatment outcomes or palliative-care delivery.[2][7][11][12][13]
• Recognise that the breast cancer diagnostic and treatment extract provides tiered clinical standards but does not specify monitoring arrangements, evaluation methods, indicators, reporting requirements or accountability procedures; metastatic and recurrent disease standards are identified as draft and not for circulation.[9][10]

Costing & Financing

Financing information is limited. External technical and financial assistance supported development of the national standards, while the standards identify staged service-resource requirements and selected infrastructure, medicine and training needs; they do not provide programme budgets, cost estimates, funding gaps or domestic financing commitments.[1][3][7]

• Record technical support from the Pacific Center of Excellence in the Elimination of Disparities at the University of Hawaii, including the National Cancer Institute’s Cancer Information Service-Pacific Region.[1]
• Record financial support through the REACH US cooperative agreement from the United States Centers for Disease Control and Prevention and from C-Change, alongside additional technical and financial support from the Secretariat of the Pacific Community and the Pacific Center of Excellence in the Elimination of Disparities.[1]
• Use core, expanded and desirable levels of provision to distinguish progressively greater service capacity and resource requirements for prevention, early detection, diagnosis and treatment.[2][3][6][9]
• Provide resource-intensive diagnostic and treatment options only at expanded or desirable levels where appropriate, including specialist pathology, imaging, surgery, radiotherapy, systemic treatment and supportive care.[9][10]
• Resource palliative care through primary-care clinics and home-based care, with oral morphine, other affordable essential medicines, nationally agreed protocols, a Cancer Resource Center and a central opioid storage and distribution centre.[7]
• Support locally adapted training curricula, community workshops, continuing medical education, a palliative-care reference group and national and international palliative-care reference centres.[7]
• Consider tobacco taxation as a policy measure to reduce consumption and reduce client costs for cessation therapies, although no revenue projections, tax rates, subsidy levels or monetary estimates are supplied.[4][5]
• Recognise that no explicit programme costs, budget allocations, unit costs, funding-source breakdowns, resource-mobilisation plans, quantified financing gaps, economic assumptions or implementation timelines are specified for prevention, screening, diagnostic, treatment or palliative-care services.[1][5][6][10][7][11][12][13]
• Recognise that no monetary values are supplied for the cited medicines, diagnostic equipment, referral arrangements, off-island treatment, workforce training, communication activities or service expansion.[6][9][7]